Back to results
US 2026/0216373 A1Published application
Gene Therapy Constructs for the Treatment of Pompe Disease
AssigneeAmicus Therapeutics, Inc.
InventorHung V. Do
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to recombinant adeno-associated virus (rAAV) delivery of an acid alpha-glucosidase (GAA) polynucleotide. The disclosure provides rAAV vectors and methods of using the rAAV vectors for GAA gene therapy for Pompe disease.
Claims26
A gene therapy vector comprising a nucleic acid construct encoding a polypeptide comprising:
- a therapeutic protein comprising acid alpha-glucosidase (GAA);
- a CIMPR-binding peptide comprising a variant IGF2 (vIGF2) peptide;
- and
- a signal peptide comprising a binding immunoglobulin protein (BiP) signal peptide.
1 more element
Dependencies are inferred from the claim text.